Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism

10. november 2026 oppdatert av: Prof. Dr. Dr. Anja Bosy-Westphal, University of Kiel

This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.

Studieoversikt

Status

Har ikke rekruttert ennå

Studietype

Intervensjonell

Registrering (Antatt)

34

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Schleswig-Holstein
      • Kiel, Schleswig-Holstein, Tyskland, 24105
        • Institute of Human Nutrition and Food Science , Department Human Nutrition
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 60 år (Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Healthy adults with overweight.
  • Age 18-60 years.
  • Body mass index (BMI) >=25 and <30 kg/m2.
  • Men and women; the study plans an equal distribution of biological sex.
  • No regular sports participation; regular sporting activity >=2 h/week is excluded.
  • German-speaking, because the study questionnaires are in German and not validated in other languages.
  • No anemia or iron deficiency based on screening hemoglobin and ferritin.
  • Women of childbearing potential must use hormonal contraception (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
  • Able and willing to provide written informed consent.

Exclusion Criteria:

  • - Individuals unable to provide informed written consent.
  • Vegetarian or vegan diet.
  • Habitual consumption of more than 5 caffeinated beverages per day.
  • Chronic diseases.
  • Regular medication use, except oral contraceptives.
  • Antibiotic use within 6 weeks before study start.
  • Anemia and/or iron deficiency.
  • Pregnancy or breastfeeding.
  • Cigarette and/or cannabis use, including vaping.
  • Food allergies and/or food intolerances.
  • Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
  • Regular sporting activity >=2 h/week.
  • Claustrophobia/fear of confined spaces because of EchoMRI assessment.
  • Active participation in another study.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Control Diet -> Diverse Diet

Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet.

Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet.

Eksperimentell: Diverse Diet -> Control Diet

Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet.

Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Postprandial Insulin
Tidsramme: 0-240 minutes

fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Postprandial Glucose
Tidsramme: 0-240 minutes

fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
C-Peptide
Tidsramme: 24 hours

Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter.

24 hours
Non-esterified fatty acids
Tidsramme: 0-240 minutes

fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
Triglycerides
Tidsramme: 0-240 minutes

fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
Appetite-relatied hormones (GLP-1, PYY, Ghrelin)
Tidsramme: 0-240 minutes

fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

0-240 minutes
Subjective Appetite
Tidsramme: 0-300 minutes

measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention.

The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side.

0-300 minutes
Energy Expenditure and macronutrient oxidation
Tidsramme: 24 hours

measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention.

24 hours
Gut microbiome composition and Microbiome diversity
Tidsramme: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.

taxonomy and function via shotgun metagenome sequencing

Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. februar 2027

Primær fullføring (Antatt)

1. september 2029

Studiet fullført (Antatt)

1. juli 2030

Datoer for studieregistrering

Først innsendt

19. oktober 2026

Først innsendt som oppfylte QC-kriteriene

10. november 2026

Først lagt ut (Faktiske)

16. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere